UBS Group AG

Position in CYTK — Cytokinetics Inc

CIK 1610520 ZURICH, V8

Back to CYTK Full portfolio

Position in CYTK

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$99,781,937

-$37,131,389 QoQ

Shares Held

1,171,287

-43.6% QoQ

Ownership

0.843%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#28

of 477 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 89% Shared 0% None 11%

Common Shares in CYTK Over Time

Shares Held

Position Value (USD)

Derivatives in CYTK

reported options exposure · as of Mar 31, 2026

CallValue

$1,641,159

CallShares

24,900

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. CYTK ranks #21 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,450,825	$1,020,369,609
2	ROIV	Roivant Sciences Ltd.	17,466,641	$618,144,423
3	PTGX	Protagonist Therapeutics, Inc	3,399,221	$416,676,508
4	VRTX	Vertex Pharmaceuticals Inc / Ma	712,259	$353,800,411
5	MRNA	Moderna, Inc.	4,463,211	$312,558,664
6	INSM	INSMED Inc	2,584,446	$275,553,630
7	ABVX	Abivax S.A.	1,844,918	$245,853,771
8	MDGL	Madrigal Pharmaceuticals, Inc.	401,708	$215,697,109

All Filings in CYTK

Export CSV

34 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$99,781,937	1,171,287	-43.6%	Shares	Defined	2026-08-13
2026-03-31	$1,641,159	24,900	+25.8%	Call	Defined	2026-05-05
2026-03-31	$136,913,326	2,077,277	+83.6%	Shares	Defined	2026-05-05
2025-12-31	$71,892,712	1,131,456	-37.3%	Shares	Defined	2026-01-29
2025-09-30	$99,106,674	1,803,251	-41.3%	Shares	Defined	2025-11-13
2025-09-30	$1,088,208	19,800	+3200.0%	Call	Defined	2025-11-13
2025-06-30	$101,454,770	3,070,665	+43.9%	Shares	Defined	2025-08-14
2025-03-31	$85,774,259	2,134,219	+77.6%	Shares	Defined	2025-05-13
2024-12-31	$56,542,030	1,201,999	+283.3%	Shares	Defined	2025-02-14
2024-09-30	$16,555,914	313,559	+4.7%	Shares	Defined	2024-11-14
2024-09-30	$31,680	600	-99.2%	Call	Defined	2024-11-14
2024-06-30	$16,232,543	299,604	+0.3%	Shares	Defined	2024-08-14
2024-03-31	$20,944,940	298,744	+8.9%	Shares	Defined	2024-05-13
2023-12-31	$22,901,974	274,308	+39.5%	Shares	Defined	2024-02-09
2023-12-31	$6,094,770	73,000	—	Call	Defined	2024-02-09
2023-12-31	$1,068,672	12,800	-86.0%	Put	Defined	2024-02-09
2023-09-30	$2,689,698	91,300	+450.0%	Put	Defined	2023-11-09
2023-09-30	$5,793,927	196,671	-34.8%	Shares	Defined	2023-11-09
2023-06-30	$541,492	16,600	0.0%	Put	Defined	2023-08-11
2023-06-30	$9,835,059	301,504	+20.4%	Shares	Defined	2023-08-11
2023-03-31	$8,809,111	250,330	-25.3%	Shares	Defined	2023-05-12
2023-03-31	$584,154	16,600	—	Put	Defined	2023-05-12
2022-12-31	$15,359,642	335,217	+58.9%	Shares	Defined	2023-02-08
2022-09-30	$10,217,958	210,897	+28.2%	Shares	Defined	2022-11-10
2022-06-30	$6,462,496	164,482	-33.7%	Shares	Defined	2022-08-10
2022-03-31	$9,129,689	248,022	+1.5%	Shares	Defined	2022-05-16
2021-12-31	$11,138,520	244,373	+81.7%	Shares	Defined	2022-02-14
2021-09-30	$4,807,172	134,504	+404.7%	Shares	Defined	2021-11-15
2021-06-30	$527,403	26,650	-69.8%	Shares	Defined	2021-08-13
2021-03-31	$2,052,787	88,254	+2690.2%	Shares	Defined	2021-05-12
2020-12-31	$65,726	3,163	+26.0%	Shares	Defined	2021-02-11
2020-09-30	$54,362	2,511	+6.8%	Shares	Defined	2020-11-12
2020-06-30	$55,436	2,352	-88.4%	Shares	Defined	2020-07-31
2020-03-31	$239,206	20,289	—	Shares	Defined	2020-05-01
No filing history on record for this holder in this stock.